Showing results (11-20 of 23) with videos related to
Sort By:
Pageof 3
Neurotoxicology|August 10, 2015
A model of neuropathic pain induced by sorafenib in the rat: Effect of dimiracetamLorenzo Di Cesare Mannelli, Mario Maresca, Carlo Farina, et al.Proceedings of the National Academy of Sciences of the United States of America|April 1, 1988
Identification of the binding subunit of the sigma-type opiate receptor by photoaffinity labeling with 1-(4-azido-2-methyl[6-3H]phenyl)-3-(2-methyl[4,6-3H]phenyl)guanidineM P Kavanaugh, B C Tester, M W Scherz, et al.The Journal of Pharmacology and Experimental Therapeutics|August 17, 2000
Stereoselective interactions of the enantiomers of chromanol 293B with human voltage-gated potassium channelsI C Yang, M W Scherz, A Bahinski, et al.Pediatrics|October 1, 1977
Nonoperative management of splenic trauma in children: a report of six consecutive casesD Z Aronson, A W Scherz, A H Einhorn, et al.Cancer Chemotherapy and Pharmacology|October 14, 2017
A rat model of FOLFOX-induced neuropathy: effects of oral dimiracetam in comparison with duloxetine and pregabalinLorenzo Di Cesare Mannelli, Mario Maresca, Laura Micheli, et al.Cells|December 23, 2022
Pharmacological Profile of MP-101, a Novel Non-racemic Mixture of R- and S-dimiracetam with Increased Potency in Rat Models of Cognition, Depression and Neuropathic PainTiziana Bonifacino, Laura Micheli, Carola Torazza, et al.European Journal of Pharmacology|October 6, 1987
Synthesis and characterization of an affinity label for brain receptors to psychotomimetic benzomorphans: differentiation of sigma-type and phencyclidine receptorsJ T Adams, P M Teal, M S Sonders, et al.Journal of Medicinal Chemistry|September 1, 1990
Synthesis and structure-activity relationships of N,N'-di-o-tolylguanidine analogues, high-affinity ligands for the haloperidol-sensitive sigma receptorM W Scherz, M Fialeix, J B Fischer, et al.Proceedings of the National Academy of Sciences of the United States of America|July 1, 1989
Synthesis and characterization of a series of diarylguanidines that are noncompetitive N-methyl-D-aspartate receptor antagonists with neuroprotective propertiesJ F Keana, R N McBurney, M W Scherz, et al.The Journal of Pharmacology and Experimental Therapeutics|May 18, 2004
Pharmacology of the urotensin-II receptor antagonist palosuran (ACT-058362; 1-[2-(4-benzyl-4-hydroxy-piperidin-1-yl)-ethyl]-3-(2-methyl-quinolin-4-yl)-urea sulfate salt): first demonstration of a pathophysiological role of the urotensin SystemMartine Clozel, Christoph Binkert, Magdalena Birker-Robaczewska, et al.Pageof 3